ESC mission
ESC mission. To improve the quality of life of the European population by reducing the impact of cardiovascular disease. European Cardiac Society. Founded in 1950 49 National Societies of cardiology More than 45,000 professional members. ESC Activities. Education
ESC mission
E N D
Presentation Transcript
ESC mission To improve the quality of life of the European population by reducing the impact of cardiovascular disease
European Cardiac Society • Founded in 1950 • 49 National Societies of cardiology • More than 45,000 professional members
ESC Activities Education • ESC guidelines for prevention and treatment of CV Disease • Seven Scientific Journals • ESC Annual Congress - Stockholm Sept 3-7; 25,000 attendees
ESC Activities A Heart Plan for Europe • Supported the declaration of the Spanish Presidency in 2002 • Consensus Conference in Partnership with the Irish Presidency 2004 • Supported the Luxemburg Declaration in 2005 on prevention of CV Disease
ESC & CVD Research • Creation of a Task Force on the future of CVD Research • Conference on the future of CV Research with DG RTD • Share the EC’s view on the future of research
The future of CV Research • Investment in cardiovascular research brings results • CVD will remain n°1 killer globally - women, underprivileged at high risk • Economic cost for the EU (direct & indirect): €300 billion/year
The future of CV Research Challenges • Clinical Research in EU has declined sharply in recent years • EU has lost its dominant position as source of new treatments since 1990 • Failing to attract young clinicians to science careers
The future of CV Research Research priorities of the next 10 years: • Understanding the biological links between atherosclerosis, hypertension, diabetes and obesity • Prediction of atherosclerosis plaque behaviour • Molecular basis of failing myocardium; Differentiation of CV cells • Understanding change in heart rhythm
The future of CV Research Research priorities of the next 10 years: 5. Individual tailored treatment • Gene & stem cell therapy • Mechanisms of ageing in the CV system • Cardiovascular vulnerability of women
The future of CV Research Research strategy for Europe: • ESC strongly supports FP7 • ESC supports a doubling of the FP7 budget • Consistent with the Lisbon strategy • to increase R&D spend as % of GDP In Europe • To reverse the decline in Europe’s R&D competitiveness
The future of CV Research Research strategy for Europe: • ESC supports the creation of a European research Council to coordinate research in Europe • ESC supports the creation of a technology platform for Europe to restore R&D competitiveness
The future of CV Research Research needs to be prioritised around the needs of the people of Europe. • Health priorities based on causes of death and disability should direct investment. • Development of new biotechnologies must be directed to solving the most pressing needs to achieve their full potential. • “Blind” technology is not the answer.
The future of CV Research Research strategy for Europe: • ESC strongly supports Framework Programme 7 and the need to build a competitive knowledge based Europe. • New technologies need to be harnessed around well prioritised health needs in order to optimise their value.
